Derivation of a new dose constraint applicable to radioactive discharges from Korean nuclear power plants through retrospective dose assessment

• Published in: Nuclear engineering and technology Vol. 54; no. 10; pp. 3660 - 3671
• Main Authors: Kim, Soyun, Cheong, Jae Hak
• Format: Journal Article
• Language: English
• Published: Elsevier B.V 01-10-2022; Elsevier; 한국원자력학회
• Subjects: Dose constraint; Nuclear power plants; Offsite dose calculation; Operational flexibility; Radioactive effluent; Retrospective assessment; 원자력공학; Radioactive effluent; Retrospective assessment; Dose constraint; Nuclear power plants; Offsite dose calculation; Operational flexibility
• ISSN: 1738-5733; 2234-358X
• DOI: 10.1016/j.net.2022.05.010

A new methodology to derive a dose constraint for radioactive effluent from a unit of nuclear power plant (NPP) through retrospective assessment was developed to reflect operational flexibility in line with international standards. The new dose constraint can retain the safety margin between the offsite dose and the past dose constraints. As case studies, the new approach was applied to 24 Korean NPPs to address the limitations of the existing seven dose constraints that do not fully comply with current international radiation protection standards. Therefore, an effective dose constraint for Korean NPPs was proposed as no less than 0.15 mSv/y, which is comparable to the international practices and previous studies (0.05–0.3 mSv/y). Although the lower bound of the equivalent dose constraint was calculated as 0.17 mSv/y, it is not proposed in this study since the compliance with the derived effective dose constraint can prevent accompanied equivalent doses to any organs from exceeding equivalent dose limits. The new framework and the case studies are expected to contribute toward and support the revision of existing dose constraints for radioactive effluent from NPPs, ensuring better compliance with the current international safety standards as well as reflect the operational flexibility in practice.